NETTER-1 data shows improved PFS with Lutathera in neuroendocrine tumours.- Novartis., 20-Oct-18

Novartis announced presentation of a new analysis of Lutathera (lutetium Lu 177 dotatate) NETTER-1 data examining the impact of Lutathera...